Steven R Loranger sold $439k of EW
director at Edwards Lifesciences Corp. 5,739 shares at an average of $76.42, traded Feb 14, 2025, filed Feb 14, 2025.
Score components
- +15RoleDirector
- +17Trade size$439k at market
- 0Share of holdings soldSold 8.7% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001225208-25-001751, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 14, 2025 | MOption exercise Common Stock | +5,739 | $45.32 | $260k | 66,111 | Feb 14, 2025 |
| Feb 14, 2025 | SOpen-market sale Common Stock | -5,739 | $76.42 | $439k | 60,372 | Feb 14, 2025 |
| Feb 14, 2025 | MOption exercise Director Stock Option (Right to Acquire)derivative | -5,739 | $0.00 | $0 | 0 | Feb 14, 2025 |
Related signals
Other insiders at Edwards Lifesciences Corp and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 0Weak | sell10b5-1 | EW Edwards Lifesciences Corp | Daniel J. Lippis CVP, TAVR | $54k | 619 | |
| 27Weak | sell 210b5-1 | EW Edwards Lifesciences Corp | Scott B. Ullem CVP, Chief Financial Officer | $797k | 11,250 | |
| 20Weak | sell 410b5-1 | EW Edwards Lifesciences Corp | Donald E Bobo Jr CVP,Strategy/Corp Development | $646k | 9,500 | |
| 0Weak | sell 410b5-1 | EW Edwards Lifesciences Corp | Daniel J. Lippis CVP, JAPAC | $28k | 400 | |
| 22Weak | sell 410b5-1 | EW Edwards Lifesciences Corp | Bernard J Zovighian CEO | $428k | 6,164 | |
| 34Weak | sell 510b5-1 | EW Edwards Lifesciences Corp | Scott B. Ullem CVP, Chief Financial Officer | $796k | 11,250 | |
| 18Weak | sell 510b5-1 | EW Edwards Lifesciences Corp | Donald E Bobo Jr CVP,Strategy/Corp Development | $492k | 6,500 | |
| 37Weak | sell 5 | EW Edwards Lifesciences Corp | Heisz Leslie Stone director | $435k | 5,739 | |
| 1Weak | sell 510b5-1 | EW Edwards Lifesciences Corp | Daniel J. Lippis CVP, JAPAC | $38k | 500 | |
| 35Weak | sell 510b5-1 | EW Edwards Lifesciences Corp | Scott B. Ullem CVP, Chief Financial Officer | $852k | 11,250 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.